Jump to main content
Jump to site search

Issue 31, 2014
Previous Article Next Article

Lipid tucaresol as an adjuvant for methamphetamine vaccine development

Author affiliations

Abstract

The immunopotentiator tucaresol was modified for incorporation into liposomes, where it was found to be a superior adjuvant to MPLA for vaccination against methamphetamine.

Graphical abstract: Lipid tucaresol as an adjuvant for methamphetamine vaccine development

Back to tab navigation

Supplementary files

Article information


Submitted
26 Jan 2014
Accepted
28 Feb 2014
First published
03 Mar 2014

Chem. Commun., 2014,50, 4079-4081
Article type
Communication
Author version available

Lipid tucaresol as an adjuvant for methamphetamine vaccine development

K. C. Collins, J. E. Schlosburg, J. W. Lockner, P. T. Bremer, B. A. Ellis and K. D. Janda, Chem. Commun., 2014, 50, 4079
DOI: 10.1039/C4CC00682H

Social activity

Search articles by author

Spotlight

Advertisements